Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Avadel Pharmaceuticals Q4 EPS $(0.38) Beats $(0.41) Estimate

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 100 percent decrease over losses of $(0.19) per share
byBenzinga Newsdesk
March 17, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 100 percent decrease over losses of $(0.19) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts